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Abstract
West Nile virus (WNV) is an important zoonotic pathogen maintained in a natural transmission cycle between
mosquitoes and birds as reservoir hosts. In dead-end hosts, such as humans, infection may result in fatal
neurologic disease translating into disease and death-related suffering and increased health care costs. In
humans, WNV may also be transmitted through blood transfusions and organ transplants. WNV is not present in
Switzerland yet, but competent vector species (especially Culex pipiens and Aedes japonicus) are prevalent and
an introduction of the virus, likely through wild birds, is expected at any time. Therefore, it is important for
Switzerland to be prepared and establish a surveillance system for WNV to initiate increased prevention
activities, such as the screening of blood and organ donations and public education activities in case virus
circulation is detected. The long-term goal of these surveillance measures would be a reduced infection rate in
humans resulting in less suffering and reduced health care costs. To provide the basis for a pragmatic and
resource-effective WNV surveillance program, this study used aliquots of serum samples of free-range laying
hens taken at the abattoir and collected in the frame of the ongoing Swiss Avian Influenza and Newcastle
Disease monitoring program for a 2-year period. All 961 aliquots were analyzed using a commercial com-
petitive WNV enzyme-linked immunosorbent assay (ELISA). The study allowed to set up sampling and
laboratory routines as a basis for future WNV surveillance activities. At this stage there is no evidence for
circulation of WNV in Switzerland.
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Introduction
West Nile virus (WNV) is a flavivirus belonging to theJapanese encephalitis virus ( JEV) group, maintained
in a transmission cycle between mosquitoes and birds. Birds
are usually asymptomatic carriers. Free-range chickens can
be used as sentinels to detect early circulation of WNV
through seroconversion (Buckley et al. 2006, Rizzoli et al.
2007). Infection of incidental hosts, such as humans, may
result in febrile illness to sometimes fatal meningoencepha-
litis. Transmission between humans may occur vertically
(transplacental or through nursing) or horizontally (through
blood or organ donations) (WHO 2011).
WNV is prevalent in parts of southern Europe with several
affected countries neighboring Switzerland, that is, Italy,
France, and Austria (Rizzo et al. 2016, Gossner et al. 2017).
In Switzerland, competent vector species, including Culex
pipiens, the principal vector of WNV (Engler et al. 2013), and
the invasive Aedes japonicus (Veronesi et al. 2018) are
widely prevalent with locally high abundances (Wagner et al.
2018), and an introduction of the virus, likely through wild
birds, is expected at any time.
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When WNV disease was classified as notifiable in 2011,
the Swiss government suggested to establish the appropriate
diagnostic methods for detection of virus and antibodies at
the Swiss reference centers for WNV. This would provide a
basis for rapid installation of a structured surveillance pro-
gram for WNV (in birds), once it is introduced to Switzer-
land. The first yearly detection may then trigger increased
prevention activities, such as the screening of blood and or-
gan donations and public education activities. The long-term
goal of these surveillance measures would be a reduced in-
fection rate in humans resulting in less suffering and reduced
health care costs.
This study tested the validity and established the labora-
tory use conditions of a commercial enzyme-linked immu-
nosorbent assay (ELISA), a frequently used method to detect
the concentration of antibodies in blood serum, at the Na-
tional Reference Centre for Rabbit and Poultry Diseases
(NRGK) to detect anti-WNV antibodies in chicken.
It was decided that the samples to test for seroconversion
had to fulfill the following criteria: they originated from
chicken that had been exposed to WNV vectors during the
WNV transmission season (May to October) and were old
enough to have developed an immune response during that
period. In addition, the samples had to be geographically as
randomly distributed as possible and—considering that the
described approach may be used as a basis for a future sur-
veillance program—that the samples were current.
All listed criteria were fulfilled by the samples taken from
free-range laying hens collected at the abattoir in the frame of
the national Avian Influenza and Newcastle Disease moni-
toring program (Swiss AI/ND-Monitoring; FSVO 2017).
Therefore, this study used aliquots of these samples with the
aim to design a pragmatic and resource-effective WNV sur-
veillance program that may be readily extended once WNV is
detected in Switzerland for the first time.
Materials and Methods
A total of 961 aliquots of free-range laying hen abattoir
serum samples were obtained from Swiss AI/ND-Monitoring
between February 2014 and November 2016. The samples
originated from 98 randomly selected flocks. All sampled
animals had appeared healthy.
In addition, 18 negative sera from specific pathogen-free
chickens, 28 positive sera of 25 field-infected horses, and 3
experimentally infected chickens were used for validation
purposes. To further confirm the trustworthiness of test results,
15 serum samples provided by ANSES (laboratory proficiency
test by Laboratoire de Sante´ Animale de Maisons-Alfort) were
used for internal validation.
All serum samples were tested with the ‘‘ID ScreenWest
Nile Competition Multi-species’’ ELISA (ID Vet, France)
according to the manufacturer’s protocol and measured on a
Multiskan Ex (Thermo Fisher Scientific, Waltham, MA).
Sample results were categorized as negative, doubtful, and
positive as instructed in the protocol. As cross-reactions with
antibodies to closely related viruses from the JEV group are
possible, samples with doubtful or positive results were sent
to the National Reference Laboratory for WNV in Germany
(Federal Research Institute for Animal Health, FLI) for con-
firmation. Negative results were considered as trustworthy.
Results
All 961 samples were analyzed for anti-WNV antibodies,
with 959 samples being tested negative. One doubtful and
one positive sample underwent a rigorous retesting at the FLI.
The same ELISA kit showed negative results and a virus
neutralization test did not detect neutralizing antibodies
against WNV, JEV, Usutu virus (USUV), or tick-borne en-
cephalitis virus (TBEV). The samples were, therefore, con-
sidered as ‘‘false positive’’ test result by the first ELISA.
The additional negative and positive sera were all tested
clearly negative and positive, respectively. The participation
in the proficiency test showed satisfactory results. Unsur-
prisingly, the three samples of the test panel containing an-
tibodies against USUV, TBEV, and JEV, respectively, were
detected as positive as well.
Discussion
A commercial competitive ELISA was successfully tested
and established at the NRGK using Swiss free-range laying
hen samples. A total of 961 samples tested negative for WNV
antibodies, suggesting that WNV is currently not circulating
in Switzerland. According to the formula given by Thrusfield
(2005) for an approximate annual number of 2.43 million
laying hens with access to an outdoor climate area in Swit-
zerland (Federal Office for Agriculture, FOAG 2016) with
the number of samples tested negative and an assumed
minimal prevalence of 5%, the maximum number of non-
detected positive free-range laying hens in Switzerland
would be 22,688. Therefore, geographically restricted small-
scale circulation between wild bird reservoir species cannot
be strictly excluded. An ongoing targeted study of the NRGK
to detect WNV RNA in Swiss wild birds might provide fur-
ther insights.
Only 2 of 961 samples initially gave false positive ELISA
results, and as expected, the cross-reactivity of the ID Vet
ELISA test with antibodies of other flaviviruses of the JEV
group, including USUV, as stated by the manufacturer, was
confirmed by the results of the proficiency test. As sentinel
chickens are suggested to be well suited for surveillance
purposes of flaviviruses, including USUV (Lelli et al. 2008),
the lack of USUV detection using a cross-reacting ELISA kit
suggests that there was no active circulation of USUV in
Switzerland during the study period (Vazquez et al. 2011).
This is surprising, as repeated outbreaks have been docu-
mented for Switzerland (FSVO 2016) and different authors
(e.g., Savini et al. 2011, Weissenbo¨ck et al. 2013) expect a
silent circulation of USUV for European countries with oc-
casional outbreaks. However, little is known about the epi-
demiology of USUV and up to now, it was not described
whether the virus is geographically evenly distributed or if it
occurs in pockets of high prevalence.
In conclusion, the commercial WNV ELISA is robust,
but positive ELISA reactions need to be reconfirmed by
flavivirus-specific neutralization assays.
The synergistic approach of this study shows that passively
acquired samples with no need to pay for extra manpower in
the field is both cost-saving and adequate. The established
sampling and laboratory routines can be used as a basis for
the creation of a structured surveillance program once it is
deemed necessary to be implemented. In addition, the sample
size—and, therefore, sensitivity of surveillance—may be
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rapidly and easily increased by including suitable aliquots of
serum samples of free-range chicken sent to the NRGK for
herd health monitoring.
This study will be ongoing, trusting that the used sampling
and analysis methods are sufficient to timely detect an es-
tablishment of WNV in Switzerland. We propose, however,
that after first detection of WNV, surveillance activities are
intensified and adjusted to the current situation to early detect
seasonal WNV circulation.
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